Ke Yi
Shanghai, 200052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Chromosome Karyotyping in Hematological Malignancies: Current Status and Future Directions.
Journal: Current medical science
Published: September 03, 2025
Concurrent NPM1::CCDC28A and BCR::ABL1 fusions in extramedullary blast crisis of chronic myeloid leukemia: A case report and literature review.
Journal: Annals of hematology
Published: July 16, 2025
Metachronous Presentation of BCL-2-Positive Lung Adenocarcinoma and Acute Myeloid Leukemia: A Case Presentation and Review of the Literature.
Journal: Case reports in oncology
Published: June 15, 2025
Multi-omics analysis of multiple myeloma patients with differential response to first-line treatment.
Journal: Clinical and experimental medicine
Published: May 29, 2023
A novel human multiple myeloma cell line with a 1q21 gain genetic abnormality and CKS1B overexpression.
Journal: Annals of translational medicine
Published: October 20, 2022
Integrated Transcriptomic Analysis Reveals a Distinctive Role of YAP1 in Extramedullary Invasion and Therapeutic Sensitivity of Multiple Myeloma.
Journal: Frontiers in oncology
Published: October 01, 2021
Bortezomib, epirubicin, and dexamethasone (PAD) results in superior free-progression survival compared to bortezomib, cyclophosphamide, and dexamethasone (VCD) treatment in non-transplantation newly diagnosed multiple myeloma patients aged between 50 to 65: a retrospective single-center analysis in non-transplant patients.
Journal: Annals of translational medicine
Published: September 29, 2021
The neutrophil-lymphocyte ratio and immunosuppressive acidic protein may be useful parameters for predicting depression among middle-aged patients with diffuse large B cell lymphoma.
Journal: Annals of palliative medicine
Published: January 26, 2021
Efficiency and Tolerability of Induction and Consolidation Therapy with Arsenic Trioxide/Bortezomib/Ascorbic Acid/Dexamethasone (ABCD) Regimen Compared to Bortezomib/Dexamethasone (BD) Regimen in Newly Diagnosed Myeloma Patients.
Journal: Cancer management and research
Published: April 16, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026